Although our study focused on the effects of Jab1 on the ER-mediated functions and we found that several non-ER target genes were not affected by Jab1 (Figure S5C), we cannot exclude the possibility that Jab1 could also contribute to HER2+ breast cancer through non-ER-dependent pathways. The gene discussed is ERBB2; the disease is breast carcinoma.